{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:55:16Z","timestamp":1761486916490},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2001,2]]},"DOI":"10.1309\/vwtk-xyt5-d0dk-06hq","type":"journal-article","created":{"date-parts":[[2003,1,8]],"date-time":"2003-01-08T15:52:37Z","timestamp":1042041157000},"page":"258-265","source":"Crossref","is-referenced-by-count":38,"title":["Diagnostic Usefulness of CD23 and FMC-7 Antigen Expression Patterns in B-Cell Lymphoma Classification"],"prefix":"10.1093","volume":"115","author":[{"given":"Diana P.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele T.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce H.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2001,2,1]]},"reference":[{"key":"E00001","first-page":"109","author":"Jaffe, ES","year":"1999","unstructured":"Jaffe ES. Hematopathology: integration of morphologic features and biologic markers for diagnosis. Mod Pathol. 1999;12:109-115.","journal-title":"Mod Pathol"},{"key":"E00002","first-page":"S8","author":"Jaffe, ES","year":"1999","unstructured":"Jaffe ES, Harris NL, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: a progress report. Am J Clin Pathol. 1999;111(suppl 1):S8-S12.","journal-title":"Am J Clin Pathol"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-0320(19971015)30:5<249::AID-CYTO6>3.0.CO;2-C","author":"Davis, BH","year":"1997","unstructured":"Davis BH, Foucar K, Szczarkowski W, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications. Cytometry. 1997;30:249-263.","journal-title":"Cytometry"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood.V84.6.1881.1881","volume":"84","author":"Fournier","year":"1994","unstructured":"Fournier S, Rubio M, Delespesse G, et al. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood. 1994;84:1881-1886.","journal-title":"Blood"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI115717","volume":"89","author":"Fournier","year":"1992","unstructured":"Fournier S, Delespesse G, Rubio M, et al. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J Clin Invest. 1992;89:1312-1321.","journal-title":"J Clin Invest"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/101.3.283","volume":"101","author":"Huh","year":"1994","unstructured":"Huh YO, Pugh WC, Kantarjian HM, et al. Detection of subgroups of chronic B-cell leukemias by FMC7 monoclonal antibody. Am J Clin Pathol. 1994;101:283-289.","journal-title":"Am J Clin Pathol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/101.3.283","volume":"101","author":"Huh","year":"1994","unstructured":"Ahmad E, Garcia DP, Davis BH. Diagnostic utility of CD23 and FMC-7 co-expression in the subclassification of B-cell lymphoproliferative disorders. Cytometry. In press.","journal-title":"Am J Clin Pathol"},{"key":"E00008","first-page":"136A","author":"Weisenberger, D","year":"1997","unstructured":"Weisenberger D. The International Lymphoma Study Group classification of non-Hodgkin's lymphoma: pathologic features from a large multicenter study. Mod Pathol. 1997;10:136A.","journal-title":"Mod Pathol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ajcp\/105.4.451","author":"Kilo, MN","year":"1996","unstructured":"Kilo MN, Dorfman DM. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma\/chronic lymphocytic leukemia from mantle cell lymphoma. Am J Clin Pathol. 1996;105:451-457.","journal-title":"Am J Clin Pathol"},{"key":"E00010","first-page":"S13","author":"Frizzera, G","year":"1999","unstructured":"Frizzera G, Wu CD, Inghirami G. The usefulness of immuno-phenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms: an update. Am J Clin Pathol. 1999;111(suppl 1):S13-S39.","journal-title":"Am J Clin Pathol"},{"key":"E00011","first-page":"326","volume":"7","author":"Dorfman","year":"1994","unstructured":"Dorfman DM, Pinkus GS. Distinction between small lymphocytic and mantle cell lymphoma by reactivity for CD23. Mod Pathol. 1994;7:326-331.","journal-title":"Mod Pathol"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0277-5379(87)90420-2","volume":"23","author":"Drexler","year":"1987","unstructured":"Drexler HG, Menon M, Gaedicke G, et al. Expression of FMC7 antigen and tartrate-resistant acid phosphatase isoenzyme in cases of B-lymphoproliferative diseases. Eur J Cancer Clin Oncol. 1987;23:61-68.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4049\/jimmunol.133.1.321","volume":"133","author":"Zola","year":"1984","unstructured":"Zola H, Moore HA, Hohmann A, et al. The antigen of mature human B cells detected by the monoclonal antibody FMC7: studies on the nature of the antigen and modulation of its expression. J Immunol. 1984;133:321-326.","journal-title":"J Immunol"},{"key":"E00014","first-page":"655","author":"Zola, H","year":"1983","unstructured":"Zola H, McNamara PJ, Moore HA, et al. Maturation of human B lymphocytes: studies with a panel of monoclonal antibodies against membrane antigens. Clin Exp Immunol. 1983;52:655-664.","journal-title":"Clin Exp Immunol"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V58.2.406.406","volume":"58","author":"Catovsky","year":"1981","unstructured":"Catovsky D, Brooks D, Bradley J, et al. Heterogeneity of B-cell leukemias demonstrated by the monoclonal antibody FMC-7. Blood. 1981;58:406-408.","journal-title":"Blood"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<71::AID-CYTO2>3.0.CO;2-F","volume":"34","author":"Hubl","year":"1998","unstructured":"Hubl W, Iturraspe J, Braylan RC. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20. Cytometry. 1998;34:71-74.","journal-title":"Cytometry"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0145-2126(86)90101-3","author":"Menon, M","year":"1986","unstructured":"Menon M, Drexler HG, Minowada J. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance. Leuk Res. 1986;10:25-28.","journal-title":"Leuk Res"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/0145-2126(86)90241-9","volume":"10","author":"Stark","year":"1986","unstructured":"Stark AN, Limbert HJ, Roberts BE, et al. Prolymphocytoid transformation of CLL: a clinical and immunological study of 22 cases. Leuk Res. 1986;10:1225-1232.","journal-title":"Leuk Res"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V90.8.2863","author":"Jennings, CD","year":"1997","unstructured":"Jennings CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood. 1997;90:2863-2892.","journal-title":"Blood"},{"key":"E00020","first-page":"6","author":"DiGiuseppe, JA","year":"1998","unstructured":"DiGiuseppe JA, Borowitz MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol. 1998;25:6-10.","journal-title":"Semin Oncol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V78.7.1795.1795","volume":"78","author":"Geisler","year":"1991","unstructured":"Geisler CH, Larsen JK, Hansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood. 1991;78:1795-1802.","journal-title":"Blood"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","author":"Harris, NL","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.","journal-title":"Blood"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00125480-199811000-00011","author":"Kurtin, PJ","year":"1998","unstructured":"Kurtin PJ. Mantle cell lymphoma. Adv Anat Pathol. 1998;5:376-398.","journal-title":"Adv Anat Pathol"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","volume":"6","author":"Norton","year":"1995","unstructured":"Norton AJ, Matthews J, Pappa V, et al. Mantle cell lymphoma: natural history defined in serially biopsied population over a 20-year period. Ann Oncol. 1995;6:249-256.","journal-title":"Ann Oncol"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","author":"Zucca, E","year":"1995","unstructured":"Zucca E, Roggero E, Pinotti G, et al. Patterns of survival in mantle cell lymphoma. Ann Oncol. 1995;6:257-262.","journal-title":"Ann Oncol"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hon.2900040304","volume":"4","author":"Hart","year":"1986","unstructured":"Hart DN, Beard ME, Hamer JW, et al. A cytological analysis of FMC-7 positive leukaemias. Hematol Oncol. 1986;4:205-212.","journal-title":"Hematol Oncol"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2141.1988.tb04203.x","volume":"68","author":"Dadmarz","year":"1988","unstructured":"Dadmarz R, Cawley JC. Heterogeneity of CLL: high CD23 antigen and alphaIFN receptor expression are features of favorable disease and of cell activation. Br J Haematol. 1988;68:279-282.","journal-title":"Br J Haematol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/115\/2\/258\/4984293\/ajcpath115-0258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T19:05:01Z","timestamp":1704740701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/VWTK-XYT5-D0DK-06HQ"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,2,1]]},"published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1309\/VWTK-XYT5-D0DK-06HQ"],"URL":"https:\/\/doi.org\/10.1309\/vwtk-xyt5-d0dk-06hq","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}